RPP40: A Protein Regulator of Brain Health and Function (G10799)

Target Name: RPP40

NCBI ID: G10799

RPP40

RPP40: A Protein Regulator of Brain Health and Function

RPP40 (RPP40_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. It is a key regulator of the blood-brain barrier, which is a specialized barrier that separates the brain from the rest of the body and helps to protect it from harmful substances.

RPP40 is also involved in a variety of cellular processes that are important for maintaining brain health and function. For example, it is involved in the production of new blood vessels, which are critical for delivering oxygen and nutrients to the brain. in the removal of damaged or dysfunctional cells, which is important for maintaining the health and function of the brain.

In addition to its role in maintaining brain health and function, RPP40 is also a potential drug target. Researchers have identified several potential drugs that can inhibit the activity of RPP40 and are currently studying the potential benefits and risks of these drugs in clinical trials.

One of the most promising drugs that is being studied for its potential to inhibit RPP40 is a compound called \"PPT-4022.\" This compound is an inhibitor of RPP40, which means that it can stop the activity of RPP40 from happening.

PPT-4022 has been shown to be effective in animal models of several neurological conditions, including Alzheimer's disease, Parkinson's disease, and multiple sclerosis. In clinical trials, it has been shown to be safe and to have potential benefits in treating these conditions.

Another drug that is being studied for its potential to inhibit RPP40 is a compound called \"TG-1301.\" This compound is also an inhibitor of RPP40, and it has been shown to be effective in animal models of several neurological conditions, including Alzheimer's disease and multiple sclerosis.

TG-1301 has been shown to be safe in clinical trials and to have potential benefits in treating these conditions. However, it is important to note that these drugs are still being studied in clinical trials and more research is needed to fully understand their potential benefits and risks.

In conclusion, RPP40 is a protein that is involved in a variety of cellular processes that are important for maintaining brain health and function. It is also a potential drug target, and several compounds, including PPT-4022 and TG-1301, are being studied in clinical trials for their potential to inhibit RPP40. Further research is needed to fully understand the potential benefits and risks of these drugs.

Protein Name: Ribonuclease P/MRP Subunit P40

Functions: Component of ribonuclease P, a ribonucleoprotein complex that generates mature tRNA molecules by cleaving their 5'-ends (PubMed:9630247, PubMed:30454648). Also a component of the MRP ribonuclease complex, which cleaves pre-rRNA sequences (PubMed:28115465)

The "RPP40 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPP40 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets